Response to letter to the editor and comment concerning "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial"
Zhang, L; Li, YM; Liu, D; Jiao, GJ; Wu, WL; Wang, HL; Liu, HC; Chen, YZ
Chen, YZ (corresponding author), Shandong Univ, Qilu Hosp, Dept Spine Surg, 107 West Culture Rd, Jinan, Peoples R China.; Chen, YZ (corresponding author), Dept Shandong Univ, Spine & Spine Cord Dis Res Ctr, Jinan, Shandong, Peoples R China.
INTERNATIONAL ORTHOPAEDICS, 2021; 45 (8): 2167
